Allergy Drops and Asthma: What You Need to Know

It depends on how well your asthma is controlled. People with mild, well-controlled asthma on a consistent treatment plan can often be candidates for allergy drops after a provider reviews their situation. Uncontrolled or severe asthma, however, is a contraindication, meaning drops should not be started until the asthma is stabilized. The reasoning is safety: if a rare systemic reaction occurred, reactive and poorly managed airways would make it harder to handle. Because asthma and allergies frequently coexist, your provider will assess your asthma control as part of determining candidacy. If your asthma is not yet well managed, the priority is getting it under control first, then revisiting immunotherapy.

Uncontrolled or severe asthma is a contraindication because it raises the risk profile of immunotherapy. Allergy drops intentionally expose you to your allergens, and while serious systemic reactions are rare, poorly controlled asthma means the airways are already inflamed and hyperreactive. If a reaction were to occur, it could be more difficult to manage in someone whose breathing is not stable. This caution is reflected in the labeling of FDA-approved sublingual tablets, which advise against starting in people with severe, unstable, or uncontrolled asthma; the tablets are approved, Allergy drops are compounded at a specialty pharmacy for each patient. The FDA does not review compounded products for safety or efficacy. The takeaway is not that asthma and immunotherapy are incompatible, but that asthma must be brought under good control before treatment is considered.

Allergen immunotherapy addresses the underlying allergic response that drives many people's respiratory symptoms, and there is evidence that treating allergic disease can support better respiratory outcomes over time for some patients. However, allergy drops are not an asthma treatment in themselves, and they are not a substitute for your prescribed asthma controller and rescue medications. Any potential benefit develops gradually over a multi-year course, and results vary from person to person with no guarantees. If you have asthma, immunotherapy should be considered as part of a broader plan supervised by your provider, who can monitor whether your overall allergic and respiratory picture improves while keeping your asthma management on track.

If you have well-controlled asthma and your provider has cleared you for allergy drops, stay alert to any change in your respiratory symptoms. Increased wheezing, more frequent coughing, chest tightness, or needing your rescue inhaler more often after starting drops are signals to pause and contact your provider before the next dose. Keep using your prescribed asthma controller medications consistently and follow your asthma action plan. Any severe shortness of breath, inability to speak in full sentences, or a rescue inhaler that is not working is a medical emergency requiring immediate care. Reporting changes early lets your provider adjust the plan and keep treatment safe.

Yes. Allergy drops are not a substitute for your asthma medications, and you should continue using your prescribed controller and rescue inhalers exactly as directed unless your provider tells you otherwise. Immunotherapy works gradually to reduce your underlying allergic sensitivity, but it does not replace the day-to-day management that keeps asthma stable. In fact, keeping your asthma well controlled with your usual medications is part of what makes immunotherapy appropriate in the first place. If over time your allergies improve and your provider believes your asthma management can be adjusted, that is a decision to make together, with monitoring. Never stop or reduce your asthma medications on your own based on starting allergy drops.